
Nopain50 mg
Drug International Ltd.
Diclofenac Potassium is a fast-acting, non-steroidal anti-inflammatory drug (NSAID) formulated as a potassium salt for rapid dissolution and onset of action.
Diclofenac Potassium is a fast-acting, non-steroidal anti-inflammatory drug (NSAID) formulated as a potassium salt for rapid dissolution and onset of action. It is indicated for the following:
Diclofenac Potassium is intended for short-term, symptomatic relief; it does not alter the underlying course of chronic inflammatory disease. The lowest effective dose should be used for the shortest duration consistent with individual treatment goals.
| Indication | Typical adult dose |
|---|---|
| Mild to moderate acute pain / post-traumatic or post-operative pain | 50 mg 2–3 times daily; some regimens use an initial 50 mg loading dose followed by 25–50 mg every 8 hours as needed |
| Primary dysmenorrhea | 50 mg three times daily, starting at the earliest onset of symptoms |
| Acute migraine attack | 50 mg at onset; may repeat 25–50 mg after 2 hours if needed, up to a maximum of 150 mg/day |
| Osteoarthritis | 100–150 mg/day in 2–3 divided doses |
| Rheumatoid arthritis | 150–200 mg/day in 3–4 divided doses |
Maximum recommended dose is generally 150 mg/day for most indications unless otherwise directed by a physician. Tablets should be swallowed whole with water and, where possible, taken on an empty stomach for faster onset; taking with food may reduce gastrointestinal upset but slows absorption.
Safety and efficacy of Diclofenac Potassium have not been established in children for most indications (see Use in Special Populations). In some markets it is used in adolescents over 14 years at doses up to 75 mg/day in divided doses, only under medical supervision.
No specific dose adjustment is established for mild-to-moderate renal impairment, but Diclofenac Potassium should be used with caution and at the lowest effective dose; it should be avoided in severe renal impairment. In hepatic impairment, use the lowest effective dose and monitor liver function, as diclofenac is extensively hepatically metabolized.
The following adverse effects have been reported with Diclofenac Potassium:
Patients should seek prompt medical attention for signs of GI bleeding (black stools, vomiting blood), chest pain, sudden weakness or slurred speech, unusual bruising/bleeding, jaundice, or severe skin reactions.
Diclofenac Potassium is contraindicated in the following situations (true absolute contraindications):
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.